Yahoo!   My Yahoo!   Mail  
Search   
Sign In
New User? Sign Up
Home > Investing > CPIX > Summary

Cumberland Pharmaceuticals, Inc.
(CPIX)

15.70USD   Up0.55 (3.63%)   
At 2:30AM IST
 Cumberland Pharmaceuticals, Inc. (NasdaqNM:CPIX) Delayed quote data 
[Chart]
1d  5d  3m  6m 
Last Trade: 15.70USD
Trade Time:2:30AM IST
Change:Up0.55 (3.63%)
Prev Close:15.15
Open:15.42
Bid:15.07 x 100
Ask:N/A
1y Target Est:20.67
Day's Range:15.02 - 16.19
52wk Range:11.78 - 17.75
Volume:93,171
Avg Vol (3m):67,355.4
Market Cap:316.10M
P/E (ttm):68.56
EPS (ttm):0.23
Div & Yield:N/A (N/A%)
Add CPIX to Portfolio   Download Data

HEADLINES

 
•UPDATE - Cumberland says injection meets main goal in study - Reuters  - Mon, Nov 23
•Caldolor(R) (Ibuprofen) Injection Demonstrates Significant Fever Reduction in Hospitalized Burn Patients - PR Newswire  - Mon, Nov 23
•CUMBERLAND PHARMACEUTICALS INC Financials - EDGAR Online Financials  - Wed, Nov 18
•CUMBERLAND PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report - EDGAR Online  - Fri, Nov 13
•New Star Analyst Rankings for Cumberland Pharmaceuticals Inc. - StarMine  - Wed, Nov 11
•CUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statement - EDGAR Online  - Wed, Nov 11
•Cumberland Pharmaceuticals earnings up 6% in 3Q - bizjournals.com  - Wed, Nov 11
•Cumberland 3Q profit rose on Caldolor sales - AP  - Tue, Nov 10
•UPDATE - Cumberland profit tops estimate, shares climb - Reuters  - Tue, Nov 10
•Cumberland Pharmaceuticals Reports 58% Increase in Net Revenue With Third Quarter 2009 Financial Results - PR Newswire  - Tue, Nov 10
» More Headlines for CPIX...

ANALYST

 
EPS Est (next year) (Dec-09) :0.20
EPS Est (in 2 years) (Dec-10) :0.48
Avg Rec (current)*:1.5
PEG Ratio:1.01
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
» Analyst Opinion» Estimates

BUSINESS SUMMARY

 
Cumberland Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on acquiring, developing, and commercializing branded prescription products for the acute care and gastroenterology markets.

» Full Company Profile